FindTrial
Sign In

The application of the Sarcopenia Index in the management of patients with heart failure.

The application of the Sarcopenia Index in the management of patients with heart failure.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092839
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-11-30
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure

Interventions

Exposure group (patients with SI below the median) and non-exposure group (patients with SI above the median).:None

Sponsors

Affiliated Hospital of Guangdong Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Over the age of 16 2.The diagnosis of heart failure meets the criteria of the "Chinese Guidelines for the Diagnosis and Treatment of Heart Failure 2018

Exclusion criteria

Exclusion criteria: 1. Patients with New York cardiac function class I; 2. Patients with too much missing ancillary examination data or blood creatinine or cystatin C; 3. Patients lost to follow-up during follow-up; 4. Patients with previously diagnosed renal failure 5. Patients (subjects) who are participating in other clinical trials; 6. Other reasons deemed unsuitable for clinical investigators by the investigators

Design outcomes

Primary

MeasureTime frame
All-cause mortality in heart failure;—

Countries

China

Contacts

Public ContactMing Li

Affiliated Hospital of Guangdong Medical University

leonlai@gdmu.edu.cn+86 759 2386146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026